GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹5,630 Cr | ₹5,881 Cr | ₹6,840 Cr | ₹7,115 Cr | ₹6,709 Cr |
What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹5,630 Cr |
| Mar2024 | ₹5,881 Cr |
| Mar2023 | ₹6,840 Cr |
| Mar2022 | ₹7,115 Cr |
| Mar2021 | ₹6,709 Cr |
How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,630 Cr | -4.27 | |
| Mar2024 | ₹5,881 Cr | -14.03 | |
| Mar2023 | ₹6,840 Cr | -3.86 | |
| Mar2022 | ₹7,115 Cr | 6.04 | |
| Mar2021 | ₹6,709 Cr | - | |
Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹55,256.2 Cr | -2.9% | -4% | 35% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -2.9% |
-4% |
35% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses